Cited 0 times in

27 12

Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research

Authors
 양규현 
Citation
 Korean Journal of Bone Metabolism (대한골대사학회지), Vol.22(3) : 87~91, 2015 
Journal Title
 Korean Journal of Bone Metabolism (대한골대사학회지) 
ISSN
 2287-6375 
Issue Date
2015
Abstract
Bisphosphonate (BP) is a useful anti-resorptive agent which decreases the risk of osteoporotic fracture by about 50%. However, recent evidences have shown its strong correlation with the occurrence of atypical femoral fracture (AFF). The longer the patient takes BP, the higher the risk of AFF. Also, the higher the drug adherence, the higher the risk of AFF. It is necessary to ask the patients who are taking BP for more than 3 years about the prodromal symptoms such as dull thigh pain. Simple radiography, bone scan, and magnetic resonance imaging (MRI) are good tools for the diagnosis of AFF. The pre-fracture lesion depicted on the hip dual energy X-ray absorptiometry (DXA) images should not be missed. BP should be stopped immediately after AFF is diagnosed and calcium and vitamin D (1,000 to 2,000 IU) should be administered. The patient should be advised not to put full weight on the injured limb. Daily subcutaneous injection of recombinant human parathyroid hormone (PTH; 1-34) is recommended if the patient can afford it. Prophylactic femoral nailing is indicated when the dreaded black line is visible in the lateral femoral cortex, especially in the subtrochanteric area.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/141710
DOI
10.11005/jbm.2015.22.3.87
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Orthopedic Surgery
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
T201504171.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse